When was NOVOS founded?

NOVOS was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Where is NOVOS located?

NOVOS is headquartered in New York City, United States. It is registered at Rīga, Kronvalda bulvāris 10 - 47.

Who is the current CEO of NOVOS?

Chris Mirabile of NOVOS. They have also founded 1 company.

How many employees does NOVOS have?

As of Aug 31, 2026, the latest employee count at NOVOS is 34.

Is NOVOS a funded company?

NOVOS is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Oct 01, 2021.

When was the latest funding round of NOVOS?

NOVOS's latest funding was a $***** Seed round on Oct 01, 2021, with participation from 4 investors. Its primary sector is Nutraceuticals Tech. In United States, the Nutraceuticals Tech sector has seen $160M in funding in 2026 to date.

Where does NOVOS rank among its competitors?

NOVOS ranks 6th amongst 103 active competitors, of which 11 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was REGENESOME, which secured $137K in Sep, 2025.

Who are the top competitors of NOVOS?

NOVOS's top competitors include Elysium, Timeline and Amazentis. Among them, REGENESOME secured the most recent funding round in September, 2025.

NOVOS - 2026 Company Profile, Team, Funding & Competitors

Company Details

Develops nutraceuticals to slow down aging. The company develops evidence-based supplements on the market for longevity and optimal health.

Website: novoslabs.com
Social
Email ID: *****@novoslabs.com
Registered Address: Rīga, Kronvalda bulvāris 10 - 47

Key Metrics

Founded Year

2019

Location

New York City, United States

Stage

Seed

Total Funding

$3.15M in 1 round

Latest Funding Round

Seed, Oct 01, 2021, $*****

Investors

Resolute Ventures & 6 more

Ranked

6^th among 103 active competitors

Employee Count

34 as on Aug 31, 2026

Similar Companies

Elysium & 105 more

View NOVOS's full profile

NOVOS is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
NOVOS CIN: 40203185155 , Latvia, Active	Dec 11, 2018	€1M - €10M (As on Dec 31, 2024)	4 (As on Dec 31, 2022)	-

NOVOS has raised a total funding of $3.15M over 1 round. Its latest funding round was a Seed round on Oct 01, 2021 for $*****. 4 investors participated in its latest round. NOVOS has 7 institutional investors.

Here is the list of recent funding rounds of NOVOS:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 01, 2021	4057171	Seed	6680025	5580144	6991546	8288132

Access funding benchmarks and valuations. Sign up today!

View details of NOVOS's funding rounds and investors

The founders of NOVOS are Chris Mirabile and Kris Verburgh. Chris Mirabile is the CEO of NOVOS.

Here are the details of NOVOS's key team members:

Chris Mirabile: Founder, CEO of NOVOS and founder of 1 other company.
Kris Verburgh: Co-Founder of NOVOS.

View details of NOVOS's Founder profiles and Board Members

NOVOS's employee count trend

NOVOS has 34 employees as of Aug 26. Here is NOVOS's employee count trend over the years:

Uncover NOVOS's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NOVOS include Elysium, Timeline and Amazentis. Here is the list of Top 10 competitors of NOVOS, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Elysium 2014, New York City (United States), Series C	Developer and manufactures of cellular health supplements	$71.2M	General Catalyst, Sprint & 19 others	70/100
2nd	Timeline 2007, Lausanne (Switzerland), Seed	Developer of clinically-tested Urolithin A supplements and skincare products	-	BOLD, Climb Ventures & 2 others	48/100
3rd	Amazentis 2007, Lausanne (Switzerland), Series C	Developing nutritional products to slow aging and improve quality of life	$8.9M	Nestlé Health Science, Waypoint Capital & 2 others	46/100
4th	Tally Health 2021, New York City (United States), Seed	Provider of biological age testing kits and cellular health supplements	$10M	Forerunner Ventures, L Catterton & 2 others	44/100
5th	Glutone 2018, Mumbai (India), Unfunded	Provider of glutathione supplements and skincare products	-	-	42/100
6th	NOVOS 2019, New York City (United States), Seed	Develops nutraceuticals to slow down aging	$3.15M	Uncommon Denominator, By The Tower & 5 others	42/100
7th	aeternum Zollikofen (Switzerland), Unfunded	Retailer of supplements and test kits focused on anti-aging solutions	-	-	34/100
8th	Wonderfeel 2018, San Francisco (United States), Unfunded	Wellness biosciences company that focuses on longevity	-	-	33/100
9th	REGENESOME 2024, Minato (Japan), Seed	Developer of supplements, foods, and cosmetics using exosome technology	$137K	Leave a Nest	31/100
10th	Ageless Partners 2021, Marina Del Rey (United States), Unfunded	Provider of nutritional supplements and coaching to improve health and wellness	-	-	30/100